Perbedaan Bank Multiarta Sentosa Tbk. dan Merck Tbk.: Bank Multiarta Sentosa Tbk. diperdagangkan di Rp3.390 (kapitalisasi pasar 4,7 T, volume 24 jam 10,8 rb), sedangkan Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb). Perbedaan utamanya: Bank Multiarta Sentosa Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar Merck Tbk., dan Merck Tbk. lebih aktif diperdagangkan (37,6 rb vs 10,8 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MASB | MERK | |
|---|---|---|
Kapitalisasi Pasar | 4,7 T | 1,7 T |
Volume | 10,8 rb | 37,6 rb |
Lot | 108 | 376 |
Perputaran | 36,52 jt | 144,47 jt |
Harga Rata-rata | 3.381,85 | 3.842,23 |
Nilai Transaksi | 36,52 jt | 144,47 jt |
Harga Ekuilibrium Indikatif | — | 3.840 |
Volume Ekuilibrium Indikatif | — | 7 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Bank Multiarta Sentosa Tbk (the Bank) was established by Deed No.201 dated July 28, 1992 of H.Saidus Sjahar, S.H. The Bank's parent company is PT Danabina Sentana which is the majority stockholder of the Bank. The majority shareholder of PT Danabina Sentana is PT Lumbung Artakencana which is a company established in Indonesia and the Bank’s ultimate shareholder that joined in business group of Wings Group.
Selengkapnya di halaman MASB →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →